Northland Capital Markets Initiates Coverage On Cardio Diagnostics Hldgs with Outperform Rating, Announces Price Target of $8
Portfolio Pulse from richadhand@benzinga.com
Northland Capital Markets analyst Carl Byrnes initiates coverage on Cardio Diagnostics Hldgs (NASDAQ:CDIO) with an Outperform rating and a price target of $8.
May 22, 2023 | 12:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cardio Diagnostics Hldgs (NASDAQ:CDIO) receives an Outperform rating and a price target of $8 from Northland Capital Markets analyst Carl Byrnes.
The Outperform rating and $8 price target from Northland Capital Markets analyst Carl Byrnes indicate a positive outlook for Cardio Diagnostics Hldgs (NASDAQ:CDIO) in the short term. This news is likely to attract investors' attention and potentially drive the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100